Skip to content

ZENSATI

Active Private limited companyfounded 2019active for 7 yearsMaalderijstraat 5, 9255 BuggenhoutKBO/BCE: BE 0721.492.136

Board

2 directors, no change since 2023
Director (not named in the articles)
appointed by deed of 19-04-2023
earlier manager, until 19-04-2023
listed in the 2025 annual accounts, filed on 26-01-2026
Director (not named in the articles)
appointed by deed of 19-04-2023
earlier manager, until 19-04-2023
listed in the 2025 annual accounts, filed on 26-01-2026

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
VAN SCHIL Ines
Director (not named in the articles)
VAN SCHIL Zita
Director (not named in the articles)
BoardEarlier
Mandates as a list
  • VAN SCHIL Ines
    • Manager (not named in the articles), appointed by deed of 26-02-2019, until 19-04-2023
    • Director (not named in the articles), appointed by deed of 19-04-2023, still in office
  • VAN SCHIL Zita
    • Manager (not named in the articles), appointed by deed of 26-02-2019, until 19-04-2023
    • Director (not named in the articles), appointed by deed of 19-04-2023, still in office

Control

This company
ZENSATI
Equity €39,070
Profit €17,047 in 2025

Capital

Contribution
€18,600
Shares
100
Contribution per share
€186
Equity per share
€391 in 2025
Source
deed of 19-04-2023

Articles of association

deed of 19-04-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Voor helft overdrager en helft koper(s) naar evenredigheid aantal verworven aandelen,ook bij weigering erfgenaam of legataris, erfgenamen en…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of December at 19:00
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Een of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen, om welke reden en op welk ogenblik”

Shareholders

At incorporation deed of 26-02-2019 ↗

Capital transactions

Capital over time
  1. 19-04-2023 Converted to unavailable equity · €18,600
  2. 26-02-2019 Incorporation · €18,600 · 100 shares

Next steps